A new immune-modulating treatment has shown promising results for treating moderate to severe eczema, delivering fast itch ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

Eczema is an itchy skin inflammation that recurs, sometimes starting in infancy and plaguing patients throughout their lives. No one knows what causes it, although people with allergic disorders ...

Breakthrough study could lead to new treatments as experts explore how skin fungi trigger debilitating skin condition ...

Nektar Therapeutics shares doubled in early trading Tuesday after the U.S. biotech firm said it reached its targets in a midstage study of its eczema treatment.

However, a 2019 study that included 63,443 women with eczema found that gluten was not a dietary risk factor for eczema. In other words, eating more or less gluten had no effect on symptoms.

Discover 7 surprising facts about spongiotic dermatitis that affect millions. Learn hidden symptoms, causes, and treatments ...

Nektar Therapeutics said on Tuesday its lead drug candidate met the main goal of a mid-stage study testing the drug in eczema patients, sending its shares up by nearly 140%. In the 393-patient global ...

Nektar, which accused Lilly of making errors in its analysis of the data, forged ahead with the programme and started the ...

Discover 8 shocking causes of hand peeling and effective treatments. Learn why your hands are peeling and get proven ...

Dermatologists share the best treatments for keratosis pilaris. Shop the best exfoliators, creams and more for keratosis ...